🇺🇸 FDA
Patent

US 7618936

Methods for treating and diagnosing cancer with WNT inhibitory Factor-1 (WIF-1)

granted A61KA61K38/1709A61P

Quick answer

US patent 7618936 (Methods for treating and diagnosing cancer with WNT inhibitory Factor-1 (WIF-1)) held by The Regents of the University of California expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
41
CPC classes
A61K, A61K38/1709, A61P, A61P35/00, A61P35/02